← Back to Clinical Trials
Recruiting NCT06850194

NCT06850194 Vertical Ramus Osteotomy With Iliac Graft Versus Sagittal Split Osteotomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06850194
Status Recruiting
Phase
Sponsor Fayoum University
Condition Mandibular Deficiency
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-02-15
Primary Completion 2026-02-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
vertical ramus osteotomy with iliac graftbilateral sagittal splitting osteotomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-02-15 with a primary completion date of 2026-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

* Patients will be collected from faculty of dentistry * bilateral vertical ramus osteotomy (VRO )with iliac graft group (group I):- 10 patients will be treated via VRO and iliac crest or * bilateral sagital spilt osteotomy (BSSO) group (group II):- 10 patients will be treated via BSSO * All patients will be studied by comprehensive clinical oral and maxillofacial examination and lateral cephalometric radiographic analyses, within 1 week before the surgery (T0), immediately after the surgery (T1), and 6 months after surgery (T2). * All lateral cephalometric radiographs and clinical photographs must be standardized for all cases. * After pre-surgical orthodontic treatment , a lateral cephalograph Will be obtained for planning the surgical movement of both jaws * Surgical models and surgical stent will be fabricated. * All surgical procedures will be performed under nasal intubation and general anesthesia to surgically reposition the maxilla in standard LeFort I setback fosteotomy; the BSSO group will be underwent BSSO, and VRO group will be underwent VRO * The bony segments will be fixed in the new position with the use of custom made plates (specific for each patient )

Eligibility Criteria

Inclusion Criteria: * patients with age above 18 years old suffered from skeletal class II with severe mandibular deficiency Exclusion Criteria: * patients with chin deviation, * severe temporomandibular joint (TMJ) symptoms. * Sever periodontal disease * pregnancy, * previous mandibular surgery, * inability to follow-up for the study protocol

Frequently Asked Questions

Who can join the NCT06850194 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Mandibular Deficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06850194 currently recruiting?

Yes, NCT06850194 is actively recruiting participants. Visit ClinicalTrials.gov or contact Fayoum University to inquire about joining.

Where is the NCT06850194 trial being conducted?

This trial is being conducted at Beni-seuf, Egypt.

Who is sponsoring the NCT06850194 clinical trial?

NCT06850194 is sponsored by Fayoum University. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology